NO20081038L - Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering - Google Patents

Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering

Info

Publication number: NO20081038L
Authority: NO; Norway
Prior art keywords: guanfacine; compositions; dosage form; pharmaceutical formulations; single dosage
Prior art date: 2005-07-28

Application number

NO20081038A

Other languages

English (en)

Norwegian (no)

Inventor

Amir Shojaei

Michael Pennick

Original Assignee

Shire Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-28

Filing date

2008-02-27

Publication date

2008-04-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37668083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081038(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-02-27 Application filed by Shire Llc filed Critical Shire Llc

2008-04-23 Publication of NO20081038L publication Critical patent/NO20081038L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Psychiatry (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20081038A 2005-07-28 2008-02-27 Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering NO20081038L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70298205P	2005-07-28	2005-07-28
PCT/US2006/029277 WO2007016284A2 (fr)	2005-07-28	2006-07-27	Preparations/compositions pharmaceutiques de guanfacine destinees a l'administration d'une dose quotidienne unique

Publications (1)

Publication Number	Publication Date
NO20081038L true NO20081038L (no)	2008-04-23

Family

ID=37668083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081038A NO20081038L (no)	2005-07-28	2008-02-27	Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering

Country Status (18)

Country	Link
US (1)	US20070048371A1 (fr)
EP (1)	EP1909766B1 (fr)
JP (2)	JP5726401B2 (fr)
KR (1)	KR20080041669A (fr)
CN (1)	CN101252917A (fr)
AR (1)	AR054595A1 (fr)
AU (1)	AU2006275718B8 (fr)
BR (1)	BRPI0615989B8 (fr)
CA (1)	CA2616181C (fr)
DK (1)	DK1909766T3 (fr)
ES (1)	ES2566395T3 (fr)
IL (1)	IL188980A0 (fr)
NO (1)	NO20081038L (fr)
NZ (1)	NZ565649A (fr)
RU (1)	RU2435573C2 (fr)
TW (1)	TW200744672A (fr)
WO (1)	WO2007016284A2 (fr)
ZA (1)	ZA200801575B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0916163D0 (en) *	2009-09-15	2009-10-28	Shire Llc	Prodrugs of guanfacine
MX354423B (es) *	2010-02-03	2018-03-02	Pharma Two B Ltd Star	Formulaciones de rasagilina de liberación prolongada y usos de las mismas.
MX2012014432A (es) *	2010-06-11	2013-05-20	Shire Llc	Terapia de combinacion con lisdexanfetamina y guanfacina de liberacion prolongada.
US20120041068A1 (en) *	2010-08-11	2012-02-16	Aptapharma, Inc.	Extended Release Pharmaceutical Preparations for Active Pharmaceutical Ingredients with pH Dependent Solubility
CN102525983A (zh) *	2010-12-31	2012-07-04	北京万全阳光医药科技有限公司	胍法新缓释片及其制备方法
CN102579381B (zh) *	2012-03-30	2013-07-10	河南中帅医药科技发展有限公司	盐酸胍法辛缓释制剂及其制备方法
MX2015012092A (es) *	2013-03-13	2016-04-06	Tris Pharma Inc	Capsulas y comprimidos solidos de benzonatato de liberacion modificada.
US9180104B2 (en) *	2013-03-13	2015-11-10	Tris Pharma, Inc.	Benzonatate modified release solid tablets and capsules
WO2016089997A1 (fr)	2014-12-02	2016-06-09	Yale University	Procédés de prévention de la neurodégénérescence du cortex associatif un mammifère
KR20180082613A (ko) *	2015-12-08	2018-07-18	아디아 바이오사이언스즈 인크.	Urat1의 강력한 억제제를 포함하는 약학 조성물
JP6656670B2 (ja) *	2016-03-11	2020-03-04	国立大学法人鹿児島大学	抗ｈｃｖ活性を有する薬剤
SI3445354T1 (sl) *	2016-04-20	2022-10-28	New Frontier Labs, Llc	Estri azelainske kisline pri zdravljenju inzulinske rezistence
WO2019136224A1 (fr) *	2018-01-05	2019-07-11	Shire Human Genetic Therapies, Inc.	Combinaisons d'amphétamine-guanfacine pour le traitement de troubles neuropsychiatriques
JP2023035359A (ja) *	2021-09-01	2023-03-13	東和薬品株式会社	グアンファシン製剤
TW202400130A (zh)	2022-06-15	2024-01-01	日商澤井製藥股份有限公司	含胍法辛鹽酸鹽製劑

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH649918A5 (de) *	1981-07-09	1985-06-28	Sandoz Ag	Verwendung von n-amidino-2-phenylacetamiden als wirkstoff zur herstellung von pharmazeutischen zubereitungen gegen schizophrenie.
IE56999B1 (en) *	1983-12-22	1992-03-11	Elan Corp Plc	Pharmaceutical formulation
US5102668A (en) *	1990-10-05	1992-04-07	Kingaform Technology, Inc.	Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
US5854290A (en) *	1995-09-21	1998-12-29	Amy F. T. Arnsten	Use of guanfacine in the treatment of behavioral disorders
DE19834573A1 (de) *	1998-07-31	2000-02-03	Bayer Ag	Doppelmetallcyanid-Katalysatoren für die Herstellung von Polyetherpolyolen
FR2781152B1 (fr) *	1998-07-20	2001-07-06	Permatec Tech Ag	Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
PE20001396A1 (es) *	1999-01-18	2000-12-23	Gruenenthal Chemie	Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
US6635277B2 (en) *	2000-04-12	2003-10-21	Wockhardt Limited	Composition for pulsatile delivery of diltiazem and process of manufacture
US6287599B1 (en) *	2000-12-20	2001-09-11	Shire Laboratories, Inc.	Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
PT1355633E (pt) *	2001-12-19	2005-05-31	Astrazeneca Ab	Nova pelicula contendo um copolimero de acrilato de etilo/metacrilato de metilo e poli(acetato de vinilo)
US6811794B2 (en) *	2001-12-20	2004-11-02	Shire Laboratories, Inc.	Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
JP2005521706A (ja) *	2002-03-29	2005-07-21	アルザ・コーポレーシヨン	体積効果的放出制御製剤
US6763509B2 (en) *	2002-09-26	2004-07-13	Sun Microsystems, Inc.	Method and apparatus for allocating decoupling capacitor cells
US20070104782A1 (en) *	2005-07-28	2007-05-10	Ibrahim Melissa E	Modified release tablet formulations with enhanced mechanical properties

2006
- 2006-07-27 RU RU2008102911/15A patent/RU2435573C2/ru active
- 2006-07-27 EP EP06788707.5A patent/EP1909766B1/fr active Active
- 2006-07-27 CN CNA2006800313902A patent/CN101252917A/zh active Pending
- 2006-07-27 NZ NZ565649A patent/NZ565649A/en unknown
- 2006-07-27 US US11/493,914 patent/US20070048371A1/en not_active Abandoned
- 2006-07-27 AU AU2006275718A patent/AU2006275718B8/en active Active
- 2006-07-27 KR KR1020087004755A patent/KR20080041669A/ko not_active Withdrawn
- 2006-07-27 JP JP2008524162A patent/JP5726401B2/ja active Active
- 2006-07-27 DK DK06788707.5T patent/DK1909766T3/en active
- 2006-07-27 CA CA2616181A patent/CA2616181C/fr not_active Expired - Fee Related
- 2006-07-27 WO PCT/US2006/029277 patent/WO2007016284A2/fr not_active Ceased
- 2006-07-27 ES ES06788707.5T patent/ES2566395T3/es active Active
- 2006-07-27 BR BRPI0615989A patent/BRPI0615989B8/pt active IP Right Grant
- 2006-07-28 TW TW095127856A patent/TW200744672A/zh unknown
- 2006-07-28 AR ARP060103292A patent/AR054595A1/es unknown
2008
- 2008-01-23 IL IL188980A patent/IL188980A0/en unknown
- 2008-02-18 ZA ZA200801575A patent/ZA200801575B/xx unknown
- 2008-02-27 NO NO20081038A patent/NO20081038L/no not_active Application Discontinuation
2012
- 2012-07-17 JP JP2012158337A patent/JP2012229253A/ja active Pending

Also Published As

Publication number	Publication date
BRPI0615989A2 (pt)	2011-05-31
CN101252917A (zh)	2008-08-27
TW200744672A (en)	2007-12-16
JP2012229253A (ja)	2012-11-22
BRPI0615989B1 (pt)	2020-05-26
BRPI0615989B8 (pt)	2021-05-25
WO2007016284A2 (fr)	2007-02-08
AU2006275718B8 (en)	2012-11-01
EP1909766B1 (fr)	2016-03-16
NZ565649A (en)	2011-03-31
AU2006275718A8 (en)	2012-11-01
RU2435573C2 (ru)	2011-12-10
CA2616181A1 (fr)	2007-02-08
DK1909766T3 (en)	2016-04-04
ZA200801575B (en)	2008-12-31
AU2006275718B2 (en)	2012-10-04
KR20080041669A (ko)	2008-05-13
JP2009502951A (ja)	2009-01-29
AR054595A1 (es)	2007-06-27
US20070048371A1 (en)	2007-03-01
CA2616181C (fr)	2015-02-17
IL188980A0 (en)	2008-08-07
AU2006275718A1 (en)	2007-02-08
EP1909766A2 (fr)	2008-04-16
JP5726401B2 (ja)	2015-06-03
ES2566395T3 (es)	2016-04-12
RU2008102911A (ru)	2009-09-10
WO2007016284A3 (fr)	2007-03-29

Publication	Publication Date	Title
NO20081038L (no)	2008-04-23	Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering
AU2008347158A8 (en)	2013-08-22	Oral pharmaceutical dosage forms
MA32200B1 (fr)	2011-04-01	Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation
SV2009003231A (es)	2009-11-09	Uso de valerato de estradiol o 17b-estradiol en combinacion con dienogest en una terapia oral para mantener y/o implementar la libido femenina
ECSP10010224A (es)	2010-07-30	Formulaciones líquidas de hormona luteinizante (lh).
UA94942C2 (ru)	2011-06-25	Фармацевтические композиции с ингибиторами dpp iv
CY1115652T1 (el)	2017-01-25	Μορφη δοσολογιας που περιεχει δυο δραστικα φαρμακευτικα συστατικα μειγματος σε διαφορετικες φυσικες μορφες
CY1111470T1 (el)	2015-08-05	Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
UA106636C2 (uk)	2014-09-25	Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
NO20080220L (no)	2008-04-21	Formuleringer med hoy medikament belastning og doseringsformer
UA116334C2 (uk)	2018-03-12	Тверді форми дозування бендамустину
CY1111442T1 (el)	2015-08-05	Ενωσεις πιπεριδινης και χρησεις αυτων
AR025938A1 (es)	2002-12-18	Nuevas composiciones farmaceuticas.
CR20110704A (es)	2012-06-15	Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amilodipina, su preparación y su aplicación terapéutica
EA201170512A1 (ru)	2011-08-30	Композиция для перорального введения
DK1987063T3 (da)	2010-01-04	Peptider og peptidderivater, fremstilling deraf samt deres anvendelse til fremstilling af en terapeutisk og/eller præventivt aktiv farmaceutisk sammensætning
EP4238556A4 (fr)	2024-09-25	Forme pharmaceutique à rétention gastrique
DE602007004348D1 (de)	2010-03-04	Arzneimittel zur behandlung von sarkoglykanopathien
MX2009008813A (es)	2010-03-03	Composicion farmaceutica que contiene floroglucinol y paracetamol.
ATE460934T1 (de)	2010-04-15	Pharmazeutische zubereitungen von ciprofloxacin
EA201290378A1 (ru)	2013-01-30	Композиции, содержащие нестероидные противовоспалительные лекарственные средства
GB0327390D0 (en)	2003-12-31	Pharmaceutical formulations
HK40090884A (en)	2023-11-24	Gastroretentive pharmaceutical dosage form
CL2012003685A1 (es)	2013-07-05	Kit farmaceutico que comprende una o mas unidades de envasado que comprenden 21 a 28 unidades de dosificacion activas diarias en que cada una comprende por lo menos 2 mg de drosperidona, sin estrogernos; uso del kit y de una composicion farmaceutica que comprende drosperidona para preparar un medicamento util como anticonceptivo.
AR070886A1 (es)	2010-05-12	Nuevo regimen de drospirenona /17 beta -estradiol, producto farmaceutico combinado y conjunto de elementos (kit) para su aplicacion

Legal Events

Date	Code	Title	Description
2010-03-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application